Crossmark

Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved

Crossref DOI link: https://doi.org/10.1007/s00210-023-02791-0

Published Online: 2023-10-25

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ragone, María Inés

Bayley, Matías

López, Sofía

Díaz, Romina G.

Consolini, Alicia E.
License Information

Text and Data Mining valid from 2023-10-25

Version of Record valid from 2023-10-25
More Information

Article History

Received: 3 May 2023

Accepted: 12 October 2023

First Online: 25 October 2023

Declarations

:

: The experiments were approved by Laboratory Animal Care and Use Committee (CICUAL) of Facultad de Ciencias Exactas, UNLP, on 6 July 2015 with extension on 16 October 2019 up to 2023 (Number 015-5-2015).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below